
The big shakeup at a badly rattled Biogen continues as 2 longtime board members hit the exits
In recent weeks we’ve seen Biogen’s CSO exit under pressure and senior marketing execs leave in an exodus as the company recoiled from a fierce backlash against the FDA’s ultra controversial approval of Aduhelm for Alzheimer’s. Now 2 longtime board members are on the way out as well as aftershocks…… Click here to view original post… […]